検索結果

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...

General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...

0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

ical has cultivated expertise as a pioneer in over-the-counter preparations. Our OTC line of gentle and effective products includes a variety of specialized preparations formulated for different sympt...

elona, Spain; CEO: Jordi Martínez Rotllan; hereinafter “Brill”). Brill specializes in R&D, drug and medical device manufacturing, and sells its products primarily in Europe and the US. The Corneal...